Creative Planning’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-40
| Closed | -$2K | – | 2327 |
|
|
2022
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 2183 |
|
|
2022
Q1 | $3K | Hold |
40
| – | – | ﹤0.01% | 2229 |
|
|
2021
Q4 | $3K | Hold |
40
| – | – | ﹤0.01% | 2072 |
|
|
2021
Q3 | $5K | Hold |
40
| – | – | ﹤0.01% | 2049 |
|
|
2021
Q2 | $6K | Sell |
40
-5
| -11% | -$750 | ﹤0.01% | 1973 |
|
|
2021
Q1 | $8K | Buy |
+45
| New | +$8K | ﹤0.01% | 2328 |
|
|
2018
Q3 | – | Sell |
-19
| Closed | -$40K | – | 2001 |
|
|
2018
Q2 | $40K | Sell |
19
-1
| -5% | -$2.11K | ﹤0.01% | 1835 |
|
|
2018
Q1 | $56K | Hold |
20
| – | – | ﹤0.01% | 1790 |
|
|
2017
Q4 | $89K | Hold |
20
| – | – | ﹤0.01% | 1732 |
|
|
2017
Q3 | $165K | Hold |
20
| – | – | ﹤0.01% | 1634 |
|
|
2017
Q2 | $100K | Buy |
20
+8
| +67% | +$40K | ﹤0.01% | 1983 |
|
|
2017
Q1 | $67K | Hold |
12
| – | – | ﹤0.01% | 2240 |
|
|
2016
Q4 | $82K | Buy |
12
+6
| +100% | +$41K | ﹤0.01% | 1988 |
|
|
2016
Q3 | $95K | Buy |
6
+2
| +50% | +$31.7K | ﹤0.01% | 1865 |
|
|
2016
Q2 | $59K | Hold |
4
| – | – | ﹤0.01% | 2015 |
|
|
2016
Q1 | $92K | Hold |
4
| – | – | ﹤0.01% | 1679 |
|
|
2015
Q4 | $77K | Hold |
4
| – | – | ﹤0.01% | 1778 |
|
|
2015
Q3 | $84K | Hold |
4
| – | – | ﹤0.01% | 1685 |
|
|
2015
Q2 | $92K | Buy |
+4
| New | +$92K | ﹤0.01% | 962 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3582 |
|
|
2014
Q4 | – | Hold |
0
| – | -$4K | – | 4176 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3348 |
|
|
2013
Q4 | – | Hold |
0
| – | -$2K | – | 3472 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3006 |
|